CIK 0001484612 · Accelerated filer<br>Smaller reporting company
Outset Medical, Inc.
Sign in to watch- Ticker
- OM
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 200514392
- Phone
- 669-231-8200
- Business address
- 3052 ORCHARD DRIVE, SAN JOSE, CA, 95134
- Former names
- Home Dialysis Plus, Ltd.
- Open-market buys, last 90 days
- $870,260
- in 1 filing
- Open-market sales, last 90 days
- $46,587
- in 3 filings
Net +$823,674. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-15 | Trigg Leslie Chair and CEO | Sale | −904 | $12.88 | $12K | 122,328 |
| 2025-08-15 | Nash Marc SVP Operations and R&D | Sale | −243 | $12.88 | $3K | 42,898 |
| 2025-08-15 | Brottem John L. General Counsel | Sale | −383 | $12.88 | $5K | 46,883 |
| 2025-06-10 | Nash Marc SVP Operations and R&D | Grant or award | +29,676 | 43,141 | ||
| 2025-06-10 | Brottem John L. General Counsel | Grant or award | +35,993 | 47,266 | ||
| 2025-06-10 | Trigg Leslie Chair and CEO | Grant or award | +65,103 | 123,232 | ||
| 2025-06-10 | Gaeta Renee Chief Financial Officer | Grant or award | +131,425 | 131,425 | ||
| 2025-06-02 | Saia Andrea Lynn Director | Grant or award | +8,983 | 12,175 | ||
| 2025-06-02 | OBOYLE KEVIN C Director | Grant or award | +8,983 | 24,118 | ||
| 2025-06-02 | LANG BRENT D. Director | Grant or award | +8,983 | 17,851 | ||
| 2025-06-02 | HACKETT PATRICK T Director | Grant or award | +8,983 | 95,172 | ||
| 2025-06-02 | GROSSMAN D KEITH Director | Grant or award | +8,983 | 13,918 | ||
| 2025-06-02 | Drexler Karen Director | Grant or award | +8,983 | 12,198 | ||
| 2025-05-15 | Trigg Leslie Chair and CEO | Sale | −935 | $17.80 | $17K | 58,129 |
| 2025-05-15 | Nash Marc SVP Operations and R&D | Sale | −252 | $17.82 | $4K | 13,465 |
| 2025-05-15 | Brottem John L. General Counsel | Sale | −396 | $17.82 | $7K | 11,273 |
| 2025-05-15 | Ahmed Nabeel Chief Financial Officer | Sale | −584 | $17.81 | $10K | 16,096 |
| 2025-05-14 | OBOYLE KEVIN C Director | Grant or award | +15,135 | 15,135 | ||
| 2025-03-10 | Trigg Leslie Chair and CEO | Option exercise | +625,000 | 625,000 | ||
| 2025-03-10 | Trigg Leslie Chair and CEO | Option exercise · Series A Non-Voting Convertible Preferred | −2,500 | 0 |
Page 3 of 8 · 141 trades